This opportunity is no longer accepting applications.
grant PAR-21-163

BPN-Biologics: Funding for Biologic Neurotherapeutics from Lead Optimization to Phase 1

This FOA funds development of biologic-based therapies for nervous system disorders, supporting projects from lead optimization through optional Phase 1 clinical testing. Eligible approaches include proteins, antibodies, peptides, gene- and cell-based therapies, and emerging microbial/microbiome treatments; awardees can work with NIH consultants and use NIH CRO resources for manufacturing, PK/…

The Blueprint Neurotherapeutics Network for Biologics (BPN-Biologics) provides support for biologic-based therapeutic discovery and development, from lead optimization through phase I clinical testing. This Funding Opportunity Announcement (FOA) supports preclinical discovery and development of …

Funding Source

Agency: National Institutes of Health
Program: FOA

Dates

Submission Deadline: August 19, 2024
Opportunity Released: March 11, 2021
Open for Submission: March 11, 2021
Application Window Closes: August 19, 2024

Documents

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.